Tissue Repair

Tissue Repair EBITDA per Share

The EBITDA per Share of Tissue Repair (TRP.AX) as of Oct 18, 2026 is -0.13 AUD. In the previous year, EBITDA per Share was -0.08 AUD — a change of 72.73% (lower).

EBITDA per Share

-0.13AUD

YoY

72.73%

Last updated:

EBITDA per Share of Tissue Repair is 2026 -0.13 AUD. EBITDA per Share of Tissue Repair was 2025 -0.08 AUD. It decreases by 72.73% lower compared to the previous year.

The Tissue Repair EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-0.01 AUD
Jan 1, 2020
-0.01 AUD
Jan 1, 2021
-0.01 AUD
Jan 1, 2022
-0.07 AUD
Jan 1, 2023
-0.09 AUD
Jan 1, 2024
-0.11 AUD
Jan 1, 2025
-0.08 AUD
Jan 1, 2026
-0.13 AUD
The Tissue Repair EBITDA per Share history
YEAREBITDA per ShareYoY
-0.13AUD+72.73%
-0.08AUD-29.20%
-0.11AUD+13.67%
-0.09AUD+35.84%
-0.07AUD+560.29%
-0.01AUD-22.75%
-0.01AUD+1.60%
-0.01AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tissue Repair Stock analysis

What does Tissue Repair do? Tissue Repair Ltd., headquartered in Sydney, Australia, operates in the Health Care sector as a biotechnology company. The firm develops advanced wound healing products for chronic wounds and post-cosmetic procedure care, with its Phase II program for TR-987 nearing completion and Phase IIB trials concluded for Glucoprime. It commercializes TR Pro+, a cosmeceutical gel for minimally invasive cosmetic procedures. Tissue Repair is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tissue Repair stock

EBITDA per Share of Tissue Repair is -0.13 AUD in 2026.

EBITDA per Share of Tissue Repair changed from -0.08 AUD to -0.13 AUD, representing a 72.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Tissue Repair since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Tissue Repair

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Tissue Repair